Fresenius Kabi Canada Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Fresenius Kabi Canada's estimated annual revenue is currently $41.4M per year.(i)
  • Fresenius Kabi Canada's estimated revenue per employee is $201,000

Employee Data

  • Fresenius Kabi Canada has 206 Employees.(i)
  • Fresenius Kabi Canada grew their employee count by 14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.7M9316%N/AN/A
#2
$12.3M6127%N/AN/A
#3
$6.6M3338%N/AN/A
#4
$17.9M933%$192.2MN/A
#5
$62.3M3109%N/AN/A
#6
$0.5M5-55%N/AN/A
#7
$11.7M5829%N/AN/A
#8
$2.3M23109%N/AN/A
#9
$1157M5756-17%N/AN/A
#10
$41.4M20614%N/AN/A
Add Company

Fresenius Kabi is a leading global health care company focusing on products for the therapy and care of critically and chronically ill patients inside and outside the hospital. We develop, produce and market pharmaceuticals and medical devices. Fresenius Kabi Canada is a diverse pharmaceutical company committed to supplying high quality, cost-effective pharmaceutical products and services to Canadians. Our product portfolio includes intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parenteral nutrition and related medical devices. With our corporate philosophy of caring for life, we are dedicated to improving patient quality of life by putting essential medicines and technologies in the hands of people who help patients across Canada. Our Canadian Headquarters is located in Toronto. We offer our employees comprehensive company paid benefits, a company matched RRSP, a generous vacation plan and competitive compensation. Join a growing team that makes a difference.

keywords:N/A

N/A

Total Funding

206

Number of Employees

$41.4M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fresenius Kabi Canada News

2022-04-20 - Glucagon Market Size, Outlook And Forecast | Novo Nordisk ...

Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals, ... North America (USA and Canada)

2022-04-20 - Global Anesthesia Drugs Market 2022 Business Players ...

Astrazeneca; Fresenius-Kabi; AbbVie; Baxter Healthcare ... North America (United States, Canada and Mexico); Europe (Germany, France, United Kingdom,...

2022-04-17 - Vasopressin Market Size, Scope And Forecast | Par ...

Par Pharmaceutical, Pfizer, Novartis, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals.

2019-09-08 - ?Global Inhalation Anesthetic Market Outlook 2019 – 2025 : AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare – Industry Segment

AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, ... Geographical Analysis: North America, United States, Canada, Mexico, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$73.2M2062%N/A
#2
N/A20632%N/A
#3
$57.6M2074%N/A
#4
$61.5M2072%N/A
#5
$61.8M20811%N/A

Fresenius Kabi Canada Executives


NameTitle
Mona SaidExecutive Assistant To Chief Executive Officer
Martin WillnerExecutive Vice President
Parminder PuniaVice President Corpoate Services